Blackburn 1981 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine, prochlorperazine, perphenazine, promazine, trifluoperazine versus placebo, not chlorpromazine withdrawal. |
Bouchard 1998 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Intervention: risperidone versus classical neuroleptics. |
Chouinard 1990 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Intervention: remoxipride versus chlorpromazine versus placebo, not chlorpromazine withdrawal. |
Crow 1986 |
Allocation: randomly assigned.
Participants: people with first episode of schizophrenia.
Interventions: chlorpromazine, fluphenazine, haloperidol, pimozide or trifluoperazine versus placebo, withdrawal study.
Outcomes: results not broken down by individual drug. |
Diamond 1960 |
Allocation: randomisation unclear.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus triflupromazine versus placebo, withdrawal study.
Outcomes: results not broken down by individual drug. |
Garfield 1966 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine, thioridazine, trifluoperazine, perphenazine, prochlorperazine versus placebo, withdrawal study.
Outcomes: results not broken down by individual drug. |
Goldberg 1967 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus acetophenazine versus fluphenazine. |
Good 1958 |
Allocation: randomly assigned, cross over design.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus placebo, withdrawal study.
Outcomes: global state, behaviour change (no usable data). |
Gross 1960 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine, perphenazine, prochlorperazine, promazine, reserpine versus placebo, not chlorpromazine withdrawal. |
Hine 1958 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus placebo, not chlorpromazine withdrawal. |
Hogarty 1973 b |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus placebo, withdrawal study.
Outcomes: global state (no usable data). |
Howanitz 1996 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Intervention: chlorpromazine versus clozapine. |
Knight 1979 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: thiothixene versus trifluoperazine versus chlorpromazine. |
Lapolla 1967 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Intervention: chlorpromazine versus etrafon. |
Levine 1997 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Intervention: chlorpromazine, perphenazine versus placebo, not chlorpromazine withdrawal. |
Mefferd 1958 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus placebo.
Outcomes: behaviour change (MSRPP), mental state, side effects‐ no usable data. |
Melnyk 1966 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: thioridazine and chlorpromazine versus placebo, withdrawal study.
Outcomes: results not broken down by individual drug. |
Montero 1971 |
Allocation: randomisation unclear.
Participant: people with schizophrenia.
Intervention: chlorpromazine and trifluoperazine versus thioridazine. |
Moss 1958 |
Allocation: not randomised. |
Pai 2001 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Intervention: reserpine versus placebo. |
Pigache 1993 |
Allocation: randomly assigned, cross over design.
Participants: people with schizophrenia.
Interventions: chlorpromazine low dose versus medium dose versus high dose. |
Pokorny 1974 |
Allocation: randomisation unclear.
Participant: people with schizophrenia.
Intervention: chlorpromazine, trifluoperazine versus thioridazine. |
Pollack 1956 |
Allocation: not randomised. |
Prien 1968 |
Allocation: randomly assigned.
Participants: people with schizophrenia.
Interventions: chlorpromazine high dose versus chlorpromazine low dose, versus placebo versus drug chosen by physician, not chlorpromazine withdrawal. |
Schiele 1961 |
Allocation: randomisation unclear.
Participants: people with schizophrenia.
Interventions: chlorpromazine versus thioridazine versus trifluoperazine versus placebo, not chlorpromazine withdrawal. |
Slotnick 1971 |
Allocation: randomisation unclear.
Participant: agitated psychiatric patients.
Intervention: haloperidol versus chlorpromazine. |
Troshinsky 1962 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Interventions: chlorpromazine, trifluoperazine, triflupromazine, thioridazine versus placebo, withdrawal study.
Outcomes: results not broken down by individual drug. |
Wilson 1982 |
Allocation: randomly assigned.
Participant: people with schizophrenia.
Intervention: chlorpromazine versus pimozide. |
Wode‐Helgodt 1981 |
Allocation: not randomised. |